Skip to main content
Premium Trial:

Request an Annual Quote

NY Genome Center Wins $1M Grant to Study Cancer Genetics Diversity

NEW YORK (GenomeWeb) — The Mark Foundation for Cancer Research announced today that it has awarded a $1 million grant to the New York Genome Center (NYGC) to investigate cancer genomics in ethnically diverse populations.

The funding will specifically support a project dubbed Polyethnic-1000, which aims to use sequencing and data analysis technologies to develop tools that can help physicians tailor cancer treatments to specific patients, with a focus on ethnic groups currently underrepresented in existing genomic databases. Data collected through the initiative is also expected to yield insights into tumor biology, cancer risk, and response to treatment across genetically diverse patient populations.

Polyethnic-1000 is being led by researchers at Cold Spring Harbor Laboratory and NYGC affiliates.

"In this study, we are creating a dynamic research platform within the greater New York area that promises to enhance the ways in which cancer is prevented, diagnosed, and treated," Harold Varmus, Weill Cornell Medicine researcher and NYGC member, said in a statement. "Polyethnic-1000 will establish a framework to enhance interactions among our region's cancer treatment centers that should improve and widen the use of genomics for all patients."

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.